{"id":"e1c75205-8cb3-571f-95f7-0923df0bc100","stable_key":"c953cca8-774f-596d-b27a-f13c2c0b5fce:dhc-bezold-jarisch-susceptibility","predicate":"causes","statement":"At high levels of dihydrocapsaicin infusion above 2.0 mg/kg/h two single episodes of transient bradycardia and hypotension were observed in 33% of healthy rats, consistent with a TRPV1-agonist-induced Bezold-Jarisch reflex, whereas in resuscitated rats multiple episodes were observed in 100% of the rats at a dose of 0.65 mg/kg/h, and this effect could be completely blocked in the resuscitated rats by pre-treatment with the muscarinic acetylcholine antagonist atropine.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"2909cb08-96d6-5380-9b3d-fefd9f1ff0e9","mechanism_event_label":"After a cardiac arrest the same drug triggers dangerous slowing of the heart at a third of the dose, and atropine stops it.","subject":{"id":"6259a8e0-9611-5f60-9e1b-53bbd8eb1afd","slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"},"object":{"id":"80ec041d-fe09-5034-96df-5e592551cd8d","slug":"bezold-jarisch-reflex","display_name":"The Bezold-Jarisch reflex of bradycardia and hypotension","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"2909cb08-96d6-5380-9b3d-fefd9f1ff0e9","stable_key":"c953cca8-774f-596d-b27a-f13c2c0b5fce:dhc-bezold-jarisch-susceptibility-event","event_type":"observed_intervention","label":"After a cardiac arrest the same drug triggers dangerous slowing of the heart at a third of the dose, and atropine stops it.","description":"At high levels of dihydrocapsaicin infusion above 2.0 mg/kg/h two single episodes of transient bradycardia and hypotension were observed in 33% of healthy rats, consistent with a TRPV1-agonist-induced Bezold-Jarisch reflex, whereas in resuscitated rats multiple episodes were observed in 100% of the rats at a dose of 0.65 mg/kg/h, and this effect could be completely blocked in the resuscitated rats by pre-treatment with the muscarinic acetylcholine antagonist atropine.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"3c9bc1b5-1a9a-5dd4-ba8c-ab7d20fc91a0","slug":"post-resuscitation-state","display_name":"The cardiovascular state after resuscitation from cardiac arrest","entity_type_key":"cellular_process"},"role":"susceptible_condition","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"15f664ac-f08e-5c21-af61-f3961b3d8d4a","slug":"atropine","display_name":"Atropine, a muscarinic acetylcholine antagonist","entity_type_key":"chemical_species"},"role":"blocking_agent","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"5c2ca60f-0af2-5b25-b2ea-f75beda1f335","slug":"heart-rate","display_name":"Heart rate","entity_type_key":"cellular_process"},"role":"affected_measure","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"631cc7e9-0d27-54c2-919b-009a569ca7b9","slug":"mean-arterial-pressure","display_name":"Mean arterial pressure","entity_type_key":"cellular_process"},"role":"affected_measure","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"6259a8e0-9611-5f60-9e1b-53bbd8eb1afd","slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"80ec041d-fe09-5034-96df-5e592551cd8d","slug":"bezold-jarisch-reflex","display_name":"The Bezold-Jarisch reflex of bradycardia and hypotension","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/dihydrocapsaicin-research/20807439.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"49bfe9de2b31cccc9afa70d322f9c96256968e48fdc033102fdb46394e617b0c\", \"start_char\": 0, \"end_char\": 1709, \"text_sha256\": \"49bfe9de2b31cccc9afa70d322f9c96256968e48fdc033102fdb46394e617b0c\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Continuous intravenous infusion in healthy rats and in rats resuscitated from cardiac arrest, with atropine pre-treatment","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Dihydrocapsaicin by continuous intravenous infusion at doses up to and beyond 2.0 mg/kg/h","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The most important safety record in this collection, and the one whose population is the same population the therapy is aimed at. It is a rat study and the episodes are described rather than counted per animal.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin.","comparator":null,"unit":null,"notes":"","entity":{"slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"After a cardiac arrest the same drug triggers dangerous slowing of the heart at a third of the dose, and atropine stops it.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[dhc-p20807439] Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin. (2010). https://pubmed.ncbi.nlm.nih.gov/20807439/ DOI: 10.1186/1471-2261-10-39","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Cardiovascular system","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"438145fd-2e26-5e04-9af5-076d5b66d488","evidence_kind":"source_excerpt","locator":"Lines 374-385","start_line":374,"end_line":385,"excerpt":"### dhc-bezold-jarisch-susceptibility\nAt high levels of dihydrocapsaicin infusion above 2.0 mg/kg/h two single episodes of transient bradycardia and hypotension were observed in 33% of healthy rats, consistent with a TRPV1-agonist-induced Bezold-Jarisch reflex, whereas in resuscitated rats multiple episodes were observed in 100% of the rats at a dose of 0.65 mg/kg/h, and this effect could be completely blocked in the resuscitated rats by pre-treatment with the muscarinic acetylcholine antagonist atropine.\nCondition category: biomarker_context\nnutrient_topic: Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin.\nplain_language: After a cardiac arrest the same drug triggers dangerous slowing of the heart at a third of the dose, and atropine stops it.\norganism: Rat\ntissue_or_cell_type: Cardiovascular system\nexperimental_model: Continuous intravenous infusion in healthy rats and in rats resuscitated from cardiac arrest, with atropine pre-treatment\nlimitations: The most important safety record in this collection, and the one whose population is the same population the therapy is aimed at. It is a rat study and the episodes are described rather than counted per animal.\nexposure: Dihydrocapsaicin by continuous intravenous infusion at doses up to and beyond 2.0 mg/kg/h\nevidence_span: {\"source_cache\": \"artifacts/dihydrocapsaicin-research/20807439.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"49bfe9de2b31cccc9afa70d322f9c96256968e48fdc033102fdb46394e617b0c\", \"start_char\": 0, \"end_char\": 1709, \"text_sha256\": \"49bfe9de2b31cccc9afa70d322f9c96256968e48fdc033102fdb46394e617b0c\"}\n[dhc-p20807439] Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin. (2010). https://pubmed.ncbi.nlm.nih.gov/20807439/ DOI: 10.1186/1471-2261-10-39","model_system":"Continuous intravenous infusion in healthy rats and in rats resuscitated from cardiac arrest, with atropine pre-treatment","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [dhc-p20807439] Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin. (2010). https://pubmed.ncbi.nlm.nih.gov/20807439/ DOI: 10.1186/1471-2261-10-39","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"263a8425-969d-5a1b-8a9b-6101ba6a26a7","stable_key":"import-c953cca8-774f-596d-b27a-f13c2c0b5fce","title":"Dihydrocapsaicin: the second capsaicinoid, the hypothermia it is used to induce, what the gut and liver do to it, and what it does without TRPV1 (2026-09-21)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"97d90ff5dc65dc321068c3e2a0525585f32b2e17eb0c6bfa0d9ef26dc2d6c5a3","revision_id":"dbdc1ad7-a05a-579d-b2aa-c4348e3efc40","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}